Filter
880
Filtered Results: 880
Text search:
Ministry
of
Health
and
Social
Welfare,
Government
of
India
Featured
Recommendations
52
New Publications
310
Language
Document type
No document type
589
Studies & Reports
139
Guidelines
70
Manuals
42
Strategic & Response Plan
15
Fact sheets
9
Training Material
6
Situation Updates
3
Infographics
3
Resource Platforms
2
App
1
Videos
1
Countries / Regions
India
285
Nepal
41
Bangladesh
33
Global
32
Myanmar / Burma
27
Asia
20
South–East Asia Region
18
Nigeria
11
Kenya
11
Indonesia
11
Tanzania
10
Ethiopia
8
Ghana
8
Liberia
7
Uganda
7
Malawi
7
Namibia
7
Sierra Leone
6
Zimbabwe
4
Pakistan
4
Zambia
4
Cambodia
4
China
4
Rwanda
4
Botswana
4
Africa
4
Guinea
3
Congo, Democratic Republic of
3
South Africa
3
Western and Central Europe
3
Laos
3
Russia
3
Philippines
2
Syria
2
Thailand
2
Mozambique
2
Ukraine
2
Lesotho
2
Sri Lanka
2
Latin America and the Carribbean
2
Bhutan
2
Eastern Europe
2
Tajikistan
2
Vietnam
2
USA
1
Haiti
1
South Sudan
1
Afghanistan
1
Eswatini/ Swaziland
1
Ecuador
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Venezuela
1
Mauritius
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
462
Public Health
49
Women & Child Health
33
Clinical Guidelines
31
Key Resources
27
Capacity Building
5
Pharmacy & Technologies
4
Annual Report MEDBOX
1
Toolboxes
Mental Health
82
Disability
63
HIV
52
COVID-19
52
TB
35
AMR
21
Caregiver
21
Planetary Health
21
Global Health Education
20
NTDs
20
Health Financing Toolbox
12
Rapid Response
10
Refugee
10
Pharmacy
10
NCDs
9
Natural Hazards
8
Conflict
7
Ebola
4
Polio
3
Specific Hazards
3
Cholera
1
Zika
1
Social Ethics
1
Health Financing
1
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania ... Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
Resistant bacteria are spreading worldwide. In collaboration with partners in India, Tanzania, South Africa and Germany, we have investigated the causes and consequences of this spread.2 This Pharma-Brief Special presents the results. It examines the risks for humans, animals and the environment. It focuses on local problems and approaches, international interactions and the re-sponsibility of doctors, farmers and consumers.
Annual report on global preparednessfor health emergencies
The next pandemic is not a question of if, but when—and the world is woefully unprepa...
This codebook outlines the set of TUFF procedures that have been developed, tested, refined, and implemented by AidData staff and affiliated facult...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely ne...
This is the third guidance note in a four-part series of notes related to impact evaluation developed by InterAction with financial support from the Rockefeller Foundation.This third guidance note, Introduction to Mixed Methods in Impact Evaluation,...
DHS WORKING PAPERS 2016 No. 126 | DEMOGRAPHIC AND HEALTH SURVEYS
Neurological, Psychiatric, and Developmental Disorders: Meeting the Challenge in the Developing World
Institute of Medicine (US) Committee on Nervous System Disorders in Developing Countries.
Wash...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because ... their inherent property for unlimited proliferation, differentiation to cells of the germ layers, oncogenic potential, unrecognised toxicities and possible involvement in pre-implantation stages of human development. The guideline therefore focuses on: 1. Monitoring mechanism and regulatory pathway for basic, clinical research and product development based on categories of research and level of manipulation. 2. Procurement of gametes, embryos and somatic cells for derivation and propagation of any stem cell lines, their banking and distribution. 3. Other important areas like international collaboration, exchange of cell/lines and education for stakeholders and advertisement.
The UNICEF-GAIN Partnership Project
The report notes that iodine deficiency is a leading cause of preventable brain damage worldwide. Insufficient iodine during pregnancy and infancy results i...
The report notes that iodine deficiency is a leading cause of preventable brain damage worldwide. Insufficient iodine during pregnancy and infancy results i...
The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care provid...
Vitamin A supplementation (VAS) programs targeted at children aged 6–59 months are implemented in many countries. By improving immune function, vitamin A (VA) reduces mortality associated with measles, diarrhea, and other illnesses. There is curre...
The purpose of this document is to provide a comprehensive overview of existing institutional arrangement for disaster management in Myanmar at all levels with an aim to make information available t...
This publication by UNAIDS, UNDP and the International Organisation for Migration examines various dimensions related to migration and HIV and AIDS...
PLoS Med 15(7): e1002615. https://doi.org/10.1371/journal. pmed.1002615
